Published online 9 March 2006
Article |
Histone deacetylase 3 binds to and regulates the GCMa transcription factor
1Graduate Institute of Biochemical Sciences, National Taiwan University Taipei 106, Taiwan 2Institute of Biological Chemistry, Academia Sinica Nankang, Taipei 115, Taiwan 3Department of Pharmacology and Cancer Biology, Duke University Durham, NC 277103, USA
*To whom correspondence should be addressed. Tel: +011 886 2 27855696, ext. 6090; Fax: +011 886 2 27889759; Email: hwchen{at}gate.sinica.edu.tw
Received December 5, 2005. Revised December 16, 2005. Accepted February 22, 2006.
Human GCMa transcription factor regulates expression of syncytin, a placental fusogenic protein mediating trophoblastic fusion. Recently, we have demonstrated that CBP-mediated GCMa acetylation underlies the activated cAMP/PKA signaling pathway that stimulates trophoblastic fusion. Because protein acetylation is a reversible modification governed by histone acetyltransferases (HATs) and histone deacetylase (HDACs), in this study we investigated the key HDACs responsible for deacetylation of GCMa and thus the reduction in GCMa activity to avoid unwanted fusion events that may have adverse effects on placental morphogenesis. We herein demonstrate that the HDAC inhibitor, trichostatin A (TSA), increases the level of acetylated GCMa and that HDAC1, 3, 4 and 5 interact with and deacetylate GCMa. Glutathione S-transferase (GST) pull-down assays further verified direct interaction between GCMa and HDAC3 or CBP and HDAC3. HDAC3 counteracts the transcriptional coactivator activity of CBP and the enhancement effect of CBP on GCMa-mediated transcriptional activation. Correlatively, we found in placental cells that HDAC3 associates with the proximal GCMa-binding site (pGBS) in the syncytin promoter and dissociates from pGBS in the presence of forskolin, which stimulates the association of CBP and GCMa with pGBS. Our studies support that trophoblastic fusion in placental morphogenesis depends on the regulation of GCMa activity by HAT and HDAC.
The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. W. Schubert, A. Abendroth, K. Kilian, T. Vogler, B. Mayr, I. Knerr, and S. Hashemolhosseini bZIP-Type transcription factors CREB and OASIS bind and stimulate the promoter of the mammalian transcription factor GCMa/Gcm1 in trophoblast cells Nucleic Acids Res., June 1, 2008; 36(11): 3834 - 3846. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Dokmanovic, C. Clarke, and P. A. Marks Histone Deacetylase Inhibitors: Overview and Perspectives Mol. Cancer Res., October 1, 2007; 5(10): 981 - 989. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-C. Chou, C. Chang, J.-H. Liu, L.-F. Chen, C.-D. Hsiao, and H. Chen Small Ubiquitin-like Modifier Modification Regulates the DNA Binding Activity of Glial Cell Missing Drosophila Homolog a J. Biol. Chem., September 14, 2007; 282(37): 27239 - 27249. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gregoire, L. Xiao, J. Nie, X. Zhang, M. Xu, J. Li, J. Wong, E. Seto, and X.-J. Yang Histone Deacetylase 3 Interacts with and Deacetylates Myocyte Enhancer Factor 2 Mol. Cell. Biol., February 15, 2007; 27(4): 1280 - 1295. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Escaffit, O. Vaute, M. Chevillard-Briet, B. Segui, Y. Takami, T. Nakayama, and D. Trouche Cleavage and Cytoplasmic Relocalization of Histone Deacetylase 3 Are Important for Apoptosis Progression Mol. Cell. Biol., January 15, 2007; 27(2): 554 - 567. [Abstract] [Full Text] [PDF] |
||||



